Main programme

>> Sunday >> Monday >> Tuesday >> Wednesday




Wednesday 04 July 2018

08:30 - 09:45
Industry sponsored symposium

08:30 - 09:30
Session 58: Cochrane session: Industry and evidence in reproductive medicine: Managing the conflicts
Chairmen
Cindy M. Farquhar, New Zealand
Chairman to be announced
08:30 - 09:00
Conflict of interest and bias: not your problem or is it?
Lisa Bero, Australia
09:00 - 09:30
We need some sunshine - making gifts from industry transparent
Paolo Vercellini, Italy

08:30 - 09:30
Session 59: Non-genetic factors influencing embryo viability
Chairmen
Borut Kovacic, Slovenia
Carmen Rubio LLuesa, Spain
08:30 - 09:00
Influence of maternal diet on preimplantation embryo development and long-term potential
Tom Fleming, United Kingdom
09:00 - 09:30
Extrinsic factors  disrupting embryo physiology in vivo and vitro
Yves Menezo, France

08:30 - 09:30
Session 60: Nurses/Midwives invited session: Towards parenthood
Chairmen
Hetty Ockhuysen, The Netherlands
Chairman to be announced
08:30 - 09:00
Antenatal care in transition from fertility treatment to parenthood
Catja Warmelink, The Netherlands
09:00 - 09:30
Focussing on infertile men's needs
Randi Sylvest, Denmark

08:30 - 09:30
Session 61: ARTHIQS session: The evolving roles of competent authorities, professional organisations and the European Commission in ART
Chairmen
Georgi Nikolov, Bulgaria
Carlos Plancha, Portugal
08:30 - 08:42
Introduction: The roots and findings of ARTHIQS
William Nigel Strang, France
08:42 - 08:54
Competent authorities: From inspectorates to support structures
Speaker to be announced
08:54 - 09:06
The relationship between competent authorities and the European Commission
Speaker to be announced
09:06 - 09:18
The professional societies relationship with competent authorities
Roy G Farquharson, United Kingdom
09:18 - 09:30
Closure: Future perspectives for competent authorities' cooperation
Carlos Plancha, Portugal

08:30 - 09:30
Product theatre

09:30 - 10:00
Coffee break

09:45 - 10:45
Product theatre

10:00 - 11:45
Session 62: From oocyte maturation in vivo to baby birth
Chairmen
Debbie Montjean, France
Karinna Lattes, Spain
10:00 - 10:15
Immature oocyte incidence: Contributing factors and effects on intracytoplasmic sperm injection cycles
Daniela Braga, Brazil
10:15 - 10:30
The influence of denudation and injection on ICSI outcome - does timing matter?
Marta Carvalho, Portugal
10:30 - 10:45
The impact of intracytoplasmic sperm injection (ICSI) on embryo development as assessed by Time-Lapse (TL) microscopy on 4126 embryos
Caitlin Sacha, U.S.A.
10:45 - 11:00
Differences in time-lapse practice: is a consensus on standards needed?
Cristina Hickman, United Kingdom
11:00 - 11:15
Deconstructing the myth of poor prognosis for fast-cleaving embryos on Day 3. Is it time to change the consensus?
Maria Carme Pons Gatell, Spain
11:15 - 11:30
Pregnancy and neonatal outcomes of embryos achieving blastulation on day 7: are they of clinical value?
Tong Du, China
11:30 - 11:45
The impact of extremely long term human embryo cryopreservation: embryonic, obstetric and neonatal outcomes
Yuan Yuan, China

10:00 - 11:45
Session 63: Male lifestyle and reproductive health
Chairmen
Lia Chkonia, Georgia
Chairman to be announced
10:00 - 10:15
Has sperm quality been declining for the past 20 years?
Chuan Huang, China
10:15 - 10:30
Male reproductive health is a key determinant of unhealthy aging: results from a longitudinal cohort study.
Eugenio Ventimiglia, Italy
10:30 - 10:45
Spermatozoa from patients with seminal alterations and advanced age show lower reproductive competence in egg donation cycles
Valentina Casciani, Italy
10:45 - 11:00
Paternal lifestyle factors and its relationship to semen quality and in vitro reproductive outcomes
Daniela Braga, Brazil
11:00 - 11:15
The association between glycemic control and semen parameters
Avi Harlev, Israel
11:15 - 11:30
The effects of Mycoplasma genitalium infection on semen: A retrospective study in infertile men of our hospital in China
Gang Liu, China
11:30 - 11:45
Effect of nut consumption on semen quality and functionality in healthy males: a randomized controlled trial
Albert Salas-Huetos, Spain

10:00 - 11:45
Session 64: Novel insights for IVF protocols
Chairmen
Frank J. Broekmans, The Netherlands
Joaquim Calaf Alsina, Spain
10:00 - 10:15
Medroxyprogesterone acetate versus ganirelix in oocyte donation cycles stimulated using GnRH antagonist protocol triggered with GnRH-agonist: a randomized controlled trial (RCT)
Rebecca Begueria, Spain
10:15 - 10:30
Triggering method dramatically alters the cumulus cell transcriptome in high and normal ovarian reserve patients
Brandon Wyse, Canada
10:30 - 10:45
Daytime variation in serum progesterone during the mid-luteal phase in women undergoing IVF treatment.
Lise Thomsen, Denmark
10:45 - 11:00
Effects of high progesterone in in-vitro fertilization cycle on DNA methylation of endometrium receptivity markers during implantation window
Yujing Xiong, Hong Kong
11:00 - 11:15
Implantation enhancement by elective Cryopreservation of all viable Embryos (ICE): randomized controlled trial (RCT) comparing the two safest approaches in IVF/ICSI for high-responders
Samuel Dos Santos-Ribeiro, Belgium
11:15 - 11:30
Oral dydrogesterone is an efficacious and safe alternative to intravaginal progesterone gel for luteal phase support in IVF: a randomized, open-label, multicenter, phase III study
Georg Griesinger, Germany
11:30 - 11:45
FSHR type is a risk factor for developing ovarian hyper stimulation syndrome during in vitro fertilisation as observed in vivo and in vitro
Hannah Nenonen, Sweden

10:00 - 11:45
Session 65: Improving IVF outcome
Chairmen
Edgardo Somigliana, Italy
Francisco Fabregues Gasol, Spain
10:00 - 10:15
Vaginal microbiota profile at the time of embryo transfer does not affect pregnancy in IVF cycles with donated oocytes
Paula Vergaro, Spain
10:15 - 10:30
Low ovarian response to stimulation in IVF can be related with activation of the NLRP3 inflammasome
Lisa Rancan, Spain
10:30 - 10:45
Do female age and body weight help to identify women who benefit from individualised gonadotropin dosing in IVF? A secondary analysis of the OPTIMIST study.
Jori Leijdekkers, The Netherlands
10:45 - 11:00
The vaginal microbiome as predictor for in vitro fertilization with or without intracytoplasmic sperm injection outcome; a prospective study
Rivka Koedooder, The Netherlands
11:00 - 11:15
Endometrial injury in women with previous in vitro fertilization and intra-cytoplasmic sperm injection failure: A systematic review and meta-analysis
Zhang Qiaoli, China
11:15 - 11:30
The use of non-donor egg IVF with embryo selection by morphology is efficient for patients aged 40-43
Fernando Prados Mondéjar, Spain
11:30 - 11:45
Autologous stem cell ovarian transplant (ASCOT), allowed 5 pregnancies in poor responders (PR) women
Nuria Pellicer De Castellvi, Spain

10:00 - 11:45
Session 66: RIF and RM: new diagnostic approaches
Chairmen
Chairman to be announced
Dolors Manau, Spain
10:00 - 10:15
Relationship between uterine natural killer (uNK) cells percentage and chronic endometritis in women with recurrent miscarriage
Yiwei Zhao, Hong Kong
10:15 - 10:30
Anti-Müllerian Hormone does not predict chance of live birth in 565 women with recurrent pregnancy loss
Sofie Bliddal, Denmark
10:30 - 10:45
The oestro-androgen dehydroepiandrosterone sulphate (DHEAS) may be a critical intracrine regulator of implantation and early pregnancy in Eumenorrhic non-PCOS women undergoing
Natachandra Chimote, India
10:45 - 11:00
Endometrial proteomic signature in recurrent implantation failure
Irem Demiral, Turkey
11:00 - 11:15
CRISPR/Cas9 genome editing to reveal the effect of implantation related genes on specific cell types which contribute to implantation process in human and mouse models
Gizem Nur Sahin, Turkey
11:15 - 11:30
T helper 1 cell level is associated with reproductive outcome of women with repeated implantation failures who received Tacrolimus treatment
Koji Nakagawa, Japan
11:30 - 11:45
Couples’ perspectives on their need for treatment, support and follow-up after recurrent pregnancy loss
Lone Schmidt, Denmark

10:00 - 11:45
Session 67: Current perspectives on preimplantation genetic testing and embryo selection
Chairmen
Ursula Eichenlaub-Ritter, Germany
Chairman to be announced
10:00 - 10:15
Improved embryo selection: a novel approach for simultaneous genomic and transcriptomic analysis from a single trophectoderm (TE) biopsy
Noga Fuchs Weizman, Canada
10:15 - 10:30
Pre-implantation genetic screening (PGS) of in vivo conceived and developed blastocysts recovered by lavage: Preliminary experience
Santiago Munne, U.S.A.
10:30 - 10:45
Comprehensive mitochondrial DNA (mtDNA) analysis and IVF outcome.
Belen Lledo, Spain
10:45 - 11:00
Improved concordance rates for aneuploidy detection in spent culture media compared to trophectoderm biopsies: a step forward towards non-invasive preimplantation genetic testing (niPGT-A)
Carmen Rubio LLuesa, Spain
11:00 - 11:15
Concordance rates among multiple trophectoderm samples and ICM remain high proving the efficacy of NGS for preimplantation genetic screening
Robert Anderson, U.S.A.
11:15 - 11:30
What is the genetic significance of blastomeres excluded from the formation of a morphologically normal blastocyst?
Caroline Pirkevi Cetinkaya, Turkey
11:30 - 11:45
Human in vitro post-implantation culture models reveal the depletion of aneuploid cells in chromosomally mosaic embryos 12 days post fertilisation
Mina Popovic, Belgium

12:00 - 13:15
Industry sponsored symposium

12:00 - 13:00
Session 68: Infertility around the globe
Chairmen
Chairman to be announced
Chairman to be announced
12:00 - 12:30
Infertility and assisted reproduction in the muslim world: Social, cultural, and religious considerations
Marcia Inhorn, U.S.A.
12:30 - 13:00
The burden of infertility and childlessness in Sub-Saharan Africa: how can it be reduced?\r
Trudie Gerrits, The Netherlands

12:00 - 13:00
Session 69: Cumulative live birth rates after utilization of all fresh and frozen embryos in ivf/icsi - the optimal endpoint
Chairmen
Siladitya Bhattacharya, United Kingdom
Miguel Angel Checa Vizcaino, Spain
12:00 - 12:30
How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Sesh Kamal Sunkara, United Kingdom
12:30 - 13:00
Cumulative live birth rates after utilization of all fresh and frozen embryos in GnRH antagonist versus agonist protocol
Mette Toftager, Denmark

12:00 - 13:00
Session 70: Preconception genetics in clinical fertility practice: how much information do we need?
Chairmen
Cristina Magli, Italy
Mireia Sandalinas, Spain
12:00 - 12:30
Increasing use of mutation screening in fertility clinics
Dagan Wells, United Kingdom
12:30 - 13:00
Genetic carrier screening in gamete donor programs
Anna Veiga, Spain

12:00 - 13:00
Session 71: Laboratory invited session: Embryo culture: changing the atmosphere
Chairmen
Kersti Lundin, Sweden
Monica Parriego, Spain
12:00 - 12:30
Epigenetic changes by stimulation and culture
Arne Sunde, Norway
12:30 - 13:00
Impact of temperature on embryo culture
Ronny Janssens, Belgium

12:00 - 13:00
Product theatre

13:00 - 14:00
Lunch break

14:00 - 15:15
Session 72: New horizons in IVF
Chairmen
Ioannis Sfontouris, Greece
Elisabet Clua Obradó, Spain
14:00 - 14:15
Using artificial intelligence (AI) and time-lapse to improve human blastocyst morphology evaluation
Marcos Meseguer Escriva, Spain
14:15 - 14:30
Optimising Machine Learning Algorithms for the Non-Invasive analysis of the embryo secretome to enhance informed decisions imediately prior to embryo transfer
Steve Butler, United Kingdom
14:30 - 14:45
Automation in the IVF laboratory: preliminary results with a new device able to do both vitrification/rewarming of mice and bovine oocytes and embryos.
Pasquale Patrizio, U.S.A.
14:45 - 15:00
Single-cell RNA-seq reveals distinct dynamic behavior of sex chromosomes during human early embryogenesis
Qing Zhou, China
15:00 - 15:15
Parallel single-cell genome and transcriptome sequencing to study chromosomal instability during human embryonic preimplantation development
Elia Fernandez, Belgium

14:00 - 15:15
Session 73: ART-related complications
Chairmen
Kelly Tilleman, Belgium
Francisca Martinez, Spain
14:00 - 14:15
Oocyte retrieval complications: an update after 23,833 procedures in an academic tertiary care ART referral center.
Paolo Emanuele Levi Setti, Italy
14:15 - 14:30
Transfer of two non-top quality embryos increases the risk of ectopic pregnancy after fresh and frozen-thawed embryo transfer
Simona Anzhel Ivanova, Finland
14:30 - 14:45
Hospitalizations due to OHSS after IVF is not diminished during the last 15 years despite presumed improvements in ovarian stimulation - National data from Denmark
Lotte Berdiin Colmorn, Denmark
14:45 - 15:00
Pregnancy after frozen-thawed embryo transfer during hormonal replacement cycle is associated with hypertensive disorders of pregnancy and placenta accreta.
Kazuki Saito, Japan
15:00 - 15:15
Pregnancy complications following assisted reproductive techniques - disentangling the role of multiple gestation
Sara Oberg, Sweden

14:00 - 15:15
Session 74: Factors affecting fertility potential PCOS women
Chairmen
Roy Homburg, United Kingdom
Chairman to be announced
14:00 - 14:15
Endometrial expression of stanniocalcin-1 (STC-1) during the menstrual cycle in healthy women and in women with polycystic ovary syndrome (PCOS)
Terhi Piltonen, Finland
14:15 - 14:30
Clomiphene citrate or gonadotrophins in women with WHO type II anovulation and CC failure; a role for EMT?
Esmée Bordewijk, The Netherlands
14:30 - 14:45
The expression and regulation of inflammatory factor interleukin-18 in the proliferative phase endometrium of PCOS
Xiaoyu Long, China
14:45 - 15:00
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome - A Cochrane Systematic Review
Sebastian Franik, Germany
Higher probability of pregnancy after frozen-embryo transfer using a freeze-all policy compared to fresh-embryo transfer in high, but not in normal responder patients: a meta-analysis
Julia Bosdou, Greece

14:00 - 15:15
Session 75: What's new in the field of implantation and early pregnancy
Chairmen
Emma Kirk, United Kingdom
Rocio Nunez - Calonge, Spain
14:00 - 14:15
Endometrial receptivity assessment using a transcriptomic approach for personalized embryo transfer
Delphine Haouzi, France
14:15 - 14:30
Live birth rate after frozen-thawed embryo transfer according to endometrial preparation: mild gonadotropin ovarian stimulation leads to increased success compared to artificial cycle
Sylvie Epelboin, France
14:30 - 14:45
Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome
Song-Po Pan, Taiwan R.O.C.
14:45 - 15:00
CSRP2BP is a novel marker in trophoblast development and preeclampsia pathogenesis
Yanlin Ma, China
15:00 - 15:15
Reproductive outcome following hyaluronic acid gel application after D&C in women with at least one previous curettage; long-term outcomes of a multicenter, prospective randomized trail.
Angelo Hooker, The Netherlands

14:00 - 15:15
Session 76: ART success and its factors
Chairmen
Georg Griesinger, Germany
Chairman to be announced
14:00 - 14:15
Transmission of oocyte DNA damage to preimplantation embryos after in vivo mouse exposure to daunorubicin and cytarabine.
Cécilia Barral, France
14:15 - 14:30
Dynamic regulation of germline-soma communication during oocyte meiotic maturation
Laleh Abbassi, Canada
14:30 - 14:45
Plasma microRNAs identified as novel markers of successful implantation.
Shirin Khanjani, United Kingdom
14:45 - 15:00
Progesterone/estradiol (P4/E2) ratio in hormone replacement cycles can predict ongoing pregnancy rates: a prospective study
Sagiri Taguchi, Japan
15:00 - 15:15
Progesterone levels but not endometrial thickness influence the effectiveness of freeze-only versus fresh embryo transfer: a prespecified subgroup analysis of a randomized clinical trial
Thi Ngoc Lan Vuong, Vietnam

14:00 - 15:15
Session 77: Female fertility from genomic studies to novel therapies
Chairmen
Andres Salumets, Estonia
Elena Labarta Demur, Spain
14:00 - 14:15
A comprehensive two-centre RNA-seq study reveals changes in endometrial and blood miRNome at mid-secretory phase in fertile women and in patients with recurrent implantation failure
Agne Velthut - Meikas, Estonia
14:15 - 14:30
Sirolimus as a new drug for treatment of RIF patients with elevated Th17/Treg Ratio: a randomized, double-blind, phase II clinical trial
Mehdi Yousefi, Iran
14:30 - 14:45
No evidences that implantation of vitrified euploid blastocysts is influenced by ovarian stimulation conducted in luteal vs follicular phase:interim analysis of a prospective multicentre study
Alberto Vaiarelli, Italy
14:45 - 15:00
Age-related gene expression profiles of immature human oocytes
Myrthe Smits, The Netherlands
15:00 - 15:15
Age related differences in the translational landscape of mammalian oocytes
Edgar Del Llano, Czech Republic